Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy

Journal of Steroid Biochemistry and Molecular Biology

Volumn 109, Issue 3-5, 2008, Pages 201-206

  Hayashi, Shin ichi ^a   Yamaguchi, Yuri ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Aromatase; Estrogen; Estrogen receptor; Microarray; Stromal cells

Indexed keywords

ESTROGEN;

ARTICLE; BIOSYNTHESIS; BREAST CANCER; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA MICROARRAY; DRUG RESPONSE; ESTROGEN SYNTHESIS; HORMONAL THERAPY; HUMAN; HUMAN CELL; MICROENVIRONMENT; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 43849112631     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.03.013     Document Type: Article

References (34)

1. Ackerman G.E., Smith M.E., Mendelson C.R., MacDonald P.C., and Simpson E.R. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J. Clin. Endocrinol. Metab. 53 (1981) 412-417
2. Tsuda H., Akiyama F., Kurosumi M., Sakamoto G., and Watanabe T. Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Jpn. J. Clin. Oncol. 28 (1998) 486-491
3. Allred D.C., Harvey J.M., Berardo M., and Clark G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 11 (1998) 155-168
4. Kurosumi M. Significance of immunohistochemical assessment of steroid hormone receptor status for breast cancer patients. Breast Cancer 10 (2003) 97-104
5. Miller W.R., Hawkins R.A., and Forrest A.M. Significance of aromatase activity in human breast cancer. Cancer Res. 42 (1982) S3365-S3368
6. O'Neill J.S., and Miller W.R. Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases. Br. J. Cancer 56 (1987) 601-604
7. Santen R.J., Santner S.J., Pauley R.J., Tait L., Kaseta J., Demers L.M., Hamilton C., Yue W., and Wang J.P. Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible?. J. Steroid Biochem. Mol. Biol. 61 (1997) 267-271
8. Harada N. Aromatase and intractinology of estrogen in hormone-dependent tumors. Oncology 57 (1997) 7-16
9. O'Neill J.S., Elton R.A., and Miller W.R. Aromatase activity in adipose tissue from breast quadrants: a link with tumor site. Br. Med. J. 296 (1988) 741-743
10. Sasano H., Nagura H., Harada N., Goukon Y., and Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum. Pathol. 25 (1994) 530-535
11. Osborne C.K., and Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J. Clin. Oncol. 23 (2005) 1616-1622
12. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., and Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 (1995) 1491-1494
13. Bunone G., Briand P.-A., Miksicek R.J., and Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15 (1996) 2174-2183
14. Rowan B.G., Weigel N.L., and O'Malley B.W. Phosphorylation of steroid receptor coactivator-1: identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J. Biol. Chem. 275 (2000) 4475-4483
15. font de Mora J., and Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 20 (2000) 5041-5047
16. Yamaguchi Y., Takei H., Suemasu K., Kobayashi Y., Kurosumi M., Harada N., and Hayashi S. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer. Cancer Res. 65 (2005) 4653-4662
17. McGuire W.L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol. 5 (1978) 428-433
18. Lapidus R.G., Nass S.J., and Davidson N.E. The loss of estrogen and progesterone receptor gene expression in human breast cancer. J. Mammary Gland Biol. Neoplasia 3 (1988) 85-94
19. Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A., and Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10 (1982) 7895-7903
20. Westley B., and Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20 (1980) 353-362
21. West M., Blanchette C., Dressman H., Huang E., Ishida S., Spang R., Zuzan H., Olson J.A., Marks J.R., and Nevins J.R. Predicting the clinical status of human breast cancer by using genes expression profiles. PNAS 98 (2001) 11462-11467
22. Gruvberger S., Ringnér M., Chen Y., Panavally S., Lao H.S., Borg A., Fernö M., Peterson C., and Meltzer P.S. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61 (2001) 5979-5984
23. Sørlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Lønning P.E., and Børresen-Dale A.-L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS 98 (2001) 10869-10874
24. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., and Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
25. Finlin B.S., Gau C.-L., Murphy G.A., Shao H., Kimel T., Seitz R.S., Chiu Y.-F., Botstein D., Brown P.O., Der C.J., Tamanoi F., Andres D.A., and Perou C.M. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J. Biol. Chem. 276 (2001) 42259-42267
26. Inoue A., Yoshida N., Omoto Y., Oguchi S., Yamori T., Kiyama R., and Hayashi S. Development of cDNA microarray for expression profiling of estrogen-responsive genes. J. Mol. Endocrinol. 29 (2002) 175-192
27. Brown A.M.C., Jeltsch J.M., Roberts M., and Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. PNAS 81 (1984) 6344-6348
28. Ghosh M.G., Thompson D.A., and Weigel R.J. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 60 (2000) 6367-6375
29. Qin C., Singh P., and Safe S. Transcriptional activation of insulin-like growth factor-binding protein-4 by 17α-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology 140 (1999) 2501-2508
30. Thenot S., Charpin M., Bonnet S., and Cavailles V. Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol. Cell. Endocrinol. 156 (1999) 85-93
31. Yoshida N., Omoto Y., Inoue A., Eguchi H., Kobayashi Y., Kurosumi M., Suemasu K., Higashi Y., Okazaki T., Kiyama R., Nakachi K., Fujita T., and Hayashi S. Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes. Cancer Sci. 95 (2004) 496-502
32. Inoue A., Omoto Y., Yamaguchi Y., Kiyama R., and Hayashi S. Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. J. Mol. Endocrinol. 32 (2004) 649-661
33. Saji S., Hayashi S., Yoshida N., Inoue A., Hirose M., Horiguchi S., Funada N., and Toi M. Therapeutic utility of histone deacetylase 6 regulation via estrogen signaling in human breast cancer MCF-7. Oncogene 24 (2005) 4531-4539
34. Zhang Z., Yamashita H., Toyama T., Sugiura H., Omoto Y., Ando Y., Mita K., Hamaguchi M., Hayashi S., and Iwase H. HDAC6 expression is correlated with better prognosis in breast cancer. Clin. Cancer Res. 10 (2004) 6962-6968